Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants

Environmental Health Perspectives

Volumn 117, Issue 4, 2009, Pages 639-644

  Calafat, Antonia M ^a   Weuve, Jennifer ^b,c   Ye, Xiaoyun ^a   Jia, Lily T ^a   Hu, Howard ^d   Ringer, Steven ^e   Huttner, Ken ^f   Hauser, Russ ^c,f  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Benzophenone; Biomonitoring; BPA; Glucuronidation; Neonate; NICU; Paraben; Triclosan

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; METHYL PARABEN; OXYBENZONE; PHENOL DERIVATIVE; PROPYL PARABEN; TRICLOSAN;

ARTICLE; BIOLOGICAL MONITORING; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GLUCURONIDATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN INTENSIVE CARE; PREMATURITY; PRIORITY JOURNAL; URINALYSIS;

BENZOPHENONES; DIETHYLHEXYL PHTHALATE; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGIC STUDIES; EQUIPMENT AND SUPPLIES; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; MALE; PARABENS; PHENOLS; PLASTICIZERS; RISK FACTORS; TRICLOSAN;

EID: 64049108375     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0800265     Document Type: Article

References (49)

1. Blake MJ, Castro L, Leeder JS, Kearns GL. 2005. Ontogeny of drug metabolizing enzymes in the neonate. Semin Fetal Neonatal Med 10:123-138.
2. Burchell B, Coughtrie M, Jackson M, Harding D, Fournel-Gigleux S, Leakey J, et al. 1989. Development of human-liver UDP-glucuronosyltransferases. Dev Pharmacol Ther 13:70-77.
3. Calafat AM, Needham LL, Silva MJ, Lambert G. 2004. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. Pediatrics 113:e429-e434.
4. Calafat AM, Wong L-Y, Ye X, Reidy JA, Needham LL. 2008a. Concentrations of the sunscreen agent benzophenone-3 in residents of the United States: National Health and Nutrition Examination Survey 2003-2004. Environ Health Perspect 116:893-897.
5. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. 2008b. Urinary concentrations of triclosan in the U.S. population: 2003-2004. Environ Health Perspect 116:303-307.
6. Calafat AM, Ye XY, Wong LY, Reidy JA, Needham LL. 2008c. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 116:39-44.
7. Cashman AL, Warshaw EM. 2005. Parabens: a review of epidemiology, structure, allergenicity, and hormonal properties. Dermatitis 16:57-66.
8. Ceccarelli I, Della Seta D, Fiorenzani P, Farabollini F, Aloisi AM. 2007. Estrogenic chemicals at puberty change ER alpha in the hypothalamus of male and female rats. Neurotoxicol Teratol 29:108-115.
9. Center for the Evaluation of Risks to Human Reproduction. 2007. NTP-CERHR Expert Panel Report on the Reproductive and Developmental Toxicity of Bisphenol A. Research Triangle Park, NC:National Toxicology Program. Available: http://cerhr.niehs.nih.gov/chemicals/bisphenol/ BPAFinalEPVF112607.pdf [accessed 26 November 2007].
10. Chapin RE, Adams J, Boekelheide K, Gray LE, Hayward SW, Lees PSJ, et al. 2008. NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res B Dev Reprod Toxicol 83:157-395.
11. Darbre PD, Harvey PW. 2008. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol 28:561-578.
12. Della Seta D, Minder I, Belloni V, Aloisi AM, Dessi-Fulgheri F, Farabollini F. 2006. Pubertal exposure to estrogenic chemi-chemicals affects behavior in juvenile and adult male rats. Horm Behav 50:301-307.
13. de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. 1999. Glucuronidation in humans - pharmacogenetic and developmental aspects. Clin Pharm 36:439-452.
14. Department of Health and Human Services. 2005. Protection of Human Subjects. 45 CFR part 46. Available: http://www.hhs.gov/ohrp/ humansubjects/guidance/45cfr46.htm [accessed 23 February 2009].
15. Durando M, Kass L, Piva J, Sonnenschein C, Soto AM, Luque EH, et al. 2007. Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect 115:80-86.
16. European Union. 2003. European Union Risk Assessment Report: 4,4′-Isopropylidenediphenol (Bisphenol A). European Union. Available: http://ecb.jrc.it/DOCUMENTS/Existing-Chemicals/ RISK_ASSESSMENT/REPORT/bisphenolareport325.pdf [accessed 12 April 2008].
17. European Union. 2008. Updated European Risk Assessment Report 4,4′-Isopropylidenediphenol (Bisphenol-A). Environment Addendum of February 2008 (to be read in conjunction with published EU RAR of BPA, 2003 for full details). European Union. Available: http://ecb.jrc.it/ documents/Existing-Chemicals/RISK_ASSESSMENT/ADDENDUM/ bisphenola_add_325.pdf [accessed 20 August 2008].
18. Food and Drug Administration. 2001. Safety Assessment of Di(2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices. Rockville, MD:Center for Devices and Radiological Health, U.S. Food and Drug Administration. Available: http://www.fda.gov/cdrh/ost/dehp-pvc.pdf [accessed 11 August 2003].
19. Gioiosa L, Fissore E, Ghirardelli G, Parmigiani S, Palanza P. 2007. Developmental exposure to low-dose estrogenic endocrine disruptors alters sex differences in exploration and emotional responses in mice. Horm Behav 52:307-316.
20. Gonzalez H, Farbrot A, Larko O, Wennberg AM. 2006. Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation. Br J Dermatol 154:337-340.
21. Goodman JE, Witorsch RJ, McConnell EE, Sipes IG, Slayton TM, Yu CJ, et al. 2008. Weight-of-evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Crit Rev Toxicol; doi.org/10.1080/10408440802157839 [Online 16 October 2008].
22. Gray GM, Cohen JT, Cunha G, Hughes C, McConnell EE, Rhomberg L, et al. 2004. Weight of the evidence evaluation of low-dose reproductive and developmental effects of bisphenol A. Hum Ecol Risk Assess 10:875-921.
23. Green R, Hauser R, Calafat AM, Weuve J, Schettler T, Ringer S, et al. 2005. Use of di(2-ethylhexyl) phthalate-containing medical products and urinary levels of mono(2-ethylhexyl) phthalate in neonatal intensive care unit infants. Environ Health Perspect 113:1222-1225.
24. Health Canada. 2008. Draft Screening Assessment for Phenol, 4,4′-(1-methyl-ethylidene) bis-(Bisphenol A). Chemical Abstracts Service Registry Number 80-05-7. Available: http://www.ec.gc.ca/ substances/ese/eng/challenge/batch2/batch2_80-05-7_en.pdf [accessed 12 September 2008].
25. Ho SM, Tang WY, de Frausto JB, Prins GS. 2006. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66:5624-5632.
26. Hornung RW, Reed LD. 1990. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 5:46-51.
27. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. 1999. Environmental toxins: exposure to bisphenol A advances puberty. Nature 401:763-764.
28. Jansen PLM, Mulder GJ, Burchell B, Bock KW. 1992. New developments in glucuronidation research: report of a workshop on "Glucuronidation, Its Role in Health and Disease." Hepatology 15:532-544.
29. Jones RD, Jampani HB, Newman JL, Lee AS. 2000. Triclosan: A review of effectiveness and safety in health care settings. Am J Infect Control 28:184-196.
30. Kang JH, Kondo F, Katayama Y. 2006. Human exposure to bisphenol A. Toxicology 226:79-89.
31. Laviola G, Gioiosa L, Adriani W, Palanza P. 2005. D-amphetamine-related reinforcing effects are reduced in mice exposed prenatally to estrogenic endocrine disruptors. Brain Research Bulletin 65:235-240.
32. Leakey JEA, Hume R, Burchell B. 1987. Development of multiple activities of UDP-glucuronyltransferase in human liver. Biochem J 243:859-861.
33. Murray TJ, Maffini MV, Ucci AA, Sonnenschein C, Soto AM. 2007. Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reprod Toxicol 23:383-390.
34. National Toxicology Program. 2008. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Bisphenol A. Available: http://cerhr.niehs.nih.gov/chemicals/bisphenol/bisphenol.pdf [accessed 3 September 2008].
35. Negishi T, Kawasaki K, Suzaki S, Maeda H, Ishii Y, Kyuwa S, et al. 2004. Behavioral alterations in response to fear-provoking stimuli and tranylcypromine induced by perinatal exposure to bisphenol A and nonylphenol in male rats. Environ Health Perspect 112:1159-1164.
36. Palanza P, Howdeshell KL, Parmigiani S, vom Saal FS. 2002. Exposure to a low dose of bisphenol A during fetal life or in adulthood alters maternal behavior in mice. Environ Health Perspect 110:415-422.
37. Ryan BC, Vandenbergh JG. 2006. Developmental exposure to environmental estrogens alters anxiety and spatial memory in female mice. Hormones and Behavior 50:85-93.
38. Schlumpf M, Cotton B, Conscience M, Haller V, Steinmann B, Lichtensteiger W. 2001. In vitro and in vivo estrogenicity of UV screens. Environ Health Perspect 109:239-244.
39. Taylor JK. 1987. Quality Assurance of Chemical Measurements. Chelsea, MI:Lewis Publishers.
40. Timms BG, Howdeshell KL, Barton L, Bradley S, Richter CA, vom Saal FS. 2005. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci USA 102:7014-7019.
41. U.S. Environmental Protection Agency. 2008. 5-Chloro-2-(2,4-dichlorophenoxy) phenol (Triclosan): Risk Assessment for the Reregistration Eligibility Decision (RED) Document. Case No 2340. DP Barcode 343544. PC Code: 054901. Washington, DC:U.S. Environmental Protection Agency.
42. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. 2007. Human exposure to bisphenol A (BPA). Reprod Toxicol 24:139-177.
43. vom Saal FS, Hughes C. 2005. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect 113:926-933.
44. Weber DJ, Rutala WA. 2006. Use of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance? Infect Control Hosp Epidemiol 27:1107-1119.
45. Weuve J, Sanchez BN, Calafat AM, Schettler T, Green RA, Hu H, et al. 2006. Exposure to phthalates in neonatal intensive care unit infants: urinary concentrations of monoesters and oxidative metabolites. Environ Health Perspect 114:1424-1431.
46. Ye XY, Bishop AM, Reidy JA, Needham LL, Calafat AM. 2006a. Parabens as urinary biomarkers of exposure in humans. Environ Health Perspect 114:1843-1846.
47. Ye XY, Bishop AM, Reidy JA, Needham LL, Calafat AM. 2007. Temporal stability of the conjugated species of bisphenol A, parabens, and other environmental phenols in human urine. J Expo Sci Environ Epidemiol 17:567-572.
48. Ye XY, Kuklenyik Z, Bishop AM, Needham LL, Calafat AM. 2006b. Quantification of the urinary concentrations of parabens in humans by on-line solid phase extraction-high performance liquid chromatography-isotope dilution tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 844:53-59.
49. Ye XY, Kuklenyik Z, Needham LL, Calafat AM. 2005. Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine. Anal Chem 77:5407-5413.